Back
Kailera Therapeutics, Inc. KLRA · Insights
Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapi... Price13.7
Market Cap1.78 B
Float89.39 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro